Experimental Models of Diabetes
eBook - ePub

Experimental Models of Diabetes

John H. McNeill, John H. McNeill

Buch teilen
  1. 424 Seiten
  2. English
  3. ePUB (handyfreundlich)
  4. Über iOS und Android verfügbar
eBook - ePub

Experimental Models of Diabetes

John H. McNeill, John H. McNeill

Angaben zum Buch
Buchvorschau
Inhaltsverzeichnis
Quellenangaben

Über dieses Buch

An extremely useful text for research Internationally renowned experts describe the models, provide data obtained with those models, and discuss the relative usefulness of models in relation to the diabetic syndrome in humans. The first section examines the most widely used model, the streptozotocin (STZ) rat, condensing a massive quantity of literature to present both the general effects of of STZ diabetes and the effects on individual organ systems. The second section discusses less well-known and more recent diabetic models, such as the BB rat, the NOD mouse and Zucker and Zucker Diabetic Fatty rat models.
Genetic models of insulin dependent diabetes mellitus (IDDM) are examined and compared to chemically induced IDDM models.

Häufig gestellte Fragen

Wie kann ich mein Abo kündigen?
Gehe einfach zum Kontobereich in den Einstellungen und klicke auf „Abo kündigen“ – ganz einfach. Nachdem du gekündigt hast, bleibt deine Mitgliedschaft für den verbleibenden Abozeitraum, den du bereits bezahlt hast, aktiv. Mehr Informationen hier.
(Wie) Kann ich Bücher herunterladen?
Derzeit stehen all unsere auf Mobilgeräte reagierenden ePub-Bücher zum Download über die App zur Verfügung. Die meisten unserer PDFs stehen ebenfalls zum Download bereit; wir arbeiten daran, auch die übrigen PDFs zum Download anzubieten, bei denen dies aktuell noch nicht möglich ist. Weitere Informationen hier.
Welcher Unterschied besteht bei den Preisen zwischen den Aboplänen?
Mit beiden Aboplänen erhältst du vollen Zugang zur Bibliothek und allen Funktionen von Perlego. Die einzigen Unterschiede bestehen im Preis und dem Abozeitraum: Mit dem Jahresabo sparst du auf 12 Monate gerechnet im Vergleich zum Monatsabo rund 30 %.
Was ist Perlego?
Wir sind ein Online-Abodienst für Lehrbücher, bei dem du für weniger als den Preis eines einzelnen Buches pro Monat Zugang zu einer ganzen Online-Bibliothek erhältst. Mit über 1 Million Büchern zu über 1.000 verschiedenen Themen haben wir bestimmt alles, was du brauchst! Weitere Informationen hier.
Unterstützt Perlego Text-zu-Sprache?
Achte auf das Symbol zum Vorlesen in deinem nächsten Buch, um zu sehen, ob du es dir auch anhören kannst. Bei diesem Tool wird dir Text laut vorgelesen, wobei der Text beim Vorlesen auch grafisch hervorgehoben wird. Du kannst das Vorlesen jederzeit anhalten, beschleunigen und verlangsamen. Weitere Informationen hier.
Ist Experimental Models of Diabetes als Online-PDF/ePub verfügbar?
Ja, du hast Zugang zu Experimental Models of Diabetes von John H. McNeill, John H. McNeill im PDF- und/oder ePub-Format sowie zu anderen beliebten Büchern aus Medicina & Teoría, práctica y referencia médicas. Aus unserem Katalog stehen dir über 1 Million Bücher zur Verfügung.

Information

Verlag
Routledge
Jahr
2018
ISBN
9781351449205
Section I
The Streptozotocin-Induced Diabetic Rat
1
Streptozotocin-Induced Diabetes: Induction, Mechanism(s), and Dose Dependency
Brian Rodrigues, Patrick Poucheret, Mary L. Battell, and John H. McNeill
CONTENTS
1.1 Introduction
1.1.1 Diabetes
1.1.2 Classification of Diabetes
1.1.2.1 Type I Diabetes
1.1.2.2 Type II Diabetes
1.2 Animal Models of Diabetes
1.2.1 NIDDM Animal Models
1.2.2 IDDM Animal Models
1.3 Streptozotocin Diabetes
1.3.1 Mechanism of the Diabetogenic Effect of STZ
1.4 Administration of STZ
1.4.1 Relationship of STZ Dose to Severity of Diabetes
1.4.2 Routes of Administration of STZ
1.4.3 STZ Diabetes in Female Rats
1.4.4 Effect of Age on Diabetogenic Action of STZ
1.4.5 Preparation of STZ
1.4.6 Susceptibility of Different Strains of Rats to STZ Diabetes
1.5 Care of STZ Diabetic Rats
1.6 Conclusion
Acknowledgments
References
1.1 Introduction
1.1.1 Diabetes
The pancreas is an organ composed of exocrine (∼98%) and endocrine (∼2%) cells. The islets of Langerhans are clusters of endocrine tissue that are dispersed throughout the exocrine pancreas. There are four major cell types present within mammalian islets. These are β-cells (insulin producing), α-cells (glucagon producing), δ-cells (somatostatin producing), and PP-cells (pancreatic polypeptide). The critical role of the pancreas in diabetes was not realized until it was discovered that complete removal of this organ resulted in hyperglycemia in dogs.1 Subsequently, the Nobel prize was awarded to researchers who discovered that insulin from pancreatic extracts dramatically reduced hyperglycemia in pancreatectomized dogs.2 Gepts3 later demonstrated specific β-cell abnormalities and inflammmatory cells in the islets of Langerhans in patients with recently diagnosed insulin-dependent diabetes, and, using quantitative morphometry, it was found that Type I diabetes was associated with a specific and complete loss of pancreatic β-cells.4
TABLE 1.1
Characteristic Features of Diabetes Subtypes
Characteristics
Type I (IDDM)
Type II (NIDDM)
Symptoms
Polyuria, polydipsia, fatigue, weight loss
Often asymptomatic in early years but may present with Type I symptoms especially in advanced stages
Age
<35 (common in youth)
>35 (frequent in adults)
Onset
Abrupt (days to weeks)
Weeks to months to years
Nutritional status
Undernourished
Majority are overweight
Ketosis
Prone
Resistant
Insulin
Mandatory
Required in <30%
Diet
Mandatory
Controls 30 to 50% cases
Ji-Cells
None (complete islet cell loss)
Varies
Islet cell antibodies
Yes
No
Family history
+in 10%
+in 30%
(Identical twins)
∼50% concordance
∼100% concordance
Glucose stimulates the β-cells of the islets to release insulin, which then promotes glucose uptake and storage in various tissues. Considering these effects, hyperglycemia was believed to be due to insulin deficiency and hypoglycemia due to insulin excess. However, with the advent of insulin radioimmunoassays, it became apparent that the majority of patients with hyperglycemia were not completely insulin dependent and, in fact, had normal or even elevated concentrations of circulating insulin. Thus, diabetes mellitus is the name given to a multiple group of disorders with different etiologies. It is characterized by derangements in carbohydrate, protein, and fat metabolism caused by the complete or relative insufficiency of insulin secretion and/or insulin action. These aberrations account for the acute (fatigue, polyuria, polydipsia, etc.) as well as chronic (retinopathy, neuropathy, nephropathy, peripheral vascular disease, heart failure, etc.) complications of the disease.5
1.1.2 Classification of Diabetes
The classification of diabetes is based principally upon clinical symptoms and, when possible, on more specific etiologic characterization. Table 1.1 summarizes the two major types of diabetes: (1) diabetes associated with insulin-deficiency (Type I, insulin-dependent, IDDM; 5 to 10% of all cases) and (2) diabetes associated with insulin resistance (Type II, noninsulin-dependent, NIDDM; 90 to 95% of all cases). Other types of diabetes include gestational diabetes, impaired glucose tolerance, and diabetes resulting from other conditions or syndromes.6
1.1.2.1 Type I Diabetes
This disease is associated with a specific and complete loss of pancreatic β-cells, leaving islets composed of an increased number of α, δ, and PP cells. Thus, Type I diabetes can be thought of as a specific β-cytectomy, a phenomenon mimicked in animals with the use of chemical agents like alloxan or streptozotocin. Autoimmune destruction of pancreatic β-cells has been suggested to be the most common cause of IDDM. Although the factors that initiate this autoimmune response are not completely understood, it is more frequent in patients with certain human leukocyte antigen tissue types. Other initiating factors include viruses (i.e., Coxsackie B4)7 and chemical toxins. Less common causes of IDDM are conditions that result in a reduction in the mass of islet cell tissue, such as may occur with several types of pancreatitis, pancreatic carcinoma, and pancreatectomy.
1.1.2.2 Type II Diabetes
Patients with NIDDM represent 90 to 95% of the diabetic population. Between 60 and 90% of those having NIDDM are obese,8 often exhibiting hyperinsulinemia and associated insulin resistance. Although the primary causes of the disease have not been identified at the molecular level, current research strongly suggests that this disease arises as a consequence of (1) failure of insulin action due to abnormalities at the cell surface (decreased affinity of the receptors for insulin) or within the cell (post-receptor defects) and (2) deficiency in insulin secretion or (3) a combination of these processes.9 Although the majority of patients with NIDDM are insulin resistant, it is undecided whether the primary molecular defect lies within the insulin signal transduction pathway or in β-cell insulin secretion.10,11
1.2 Animal Models of Diabetes
Animal models featuring physiological and pathological changes characteristic of each diabetes subtype are important to understand this complex disease better and to propose potential treatments. For example, specific etiological factors and/or genetic backgrounds can be selected and combined to produce a particular type of experimental diabetes, allowing the researcher to explore particular biochemical or anatomical alterations. In this way, animal models can provide a means to study disturbances found in human diabetes.
1.2.1 NIDDM Animal Models
The genetic NIDDM models are produced through selective breeding, spontaneous mutations, or genetic engineering. Some examples include the db/db mouse, ob/ob mouse, KK mouse, NZO mouse, fa/fa Zucker rat, and fa/fa diabetic Zucker rat. Most of these models demonstrate various degrees of glycemia, insulinemia, and obesity. Chemically induced NIDDM is obtained through injection of agents that produce the desired pathology. The most commonly used agent is streptozotocin (STZ). A mild and stable form of diabetes, resembling Type II human diabetes, is produced by a single dose of STZ (90 mg/kg i.v.) in 2-day-old neonatal rats.12 The induced β-cell injury is followed by limited regeneration, primarily as a result of ductal budding rather than mitosi...

Inhaltsverzeichnis